Phase II study of VP16-213 (Etoposide) in refractory metastatic breast carcinoma
- 1 April 1982
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 7 (2-3) , 223-225
- https://doi.org/10.1007/bf00254555
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- VINBLASTINE GIVEN AS A CONTINUOUS 5-DAY INFUSION IN THE TREATMENT OF REFRACTORY ADVANCED BREAST-CANCER1980
- Etoposide (VP-16-213)Cancer Treatment Reviews, 1979
- PHASE-II STUDY WITH SEQUENTIAL L-ASPARAGINASE AND METHOTREXATE IN ADVANCED REFRACTORY BREAST-CANCER1979
- Mitomycin-C and megestrol acetate in treatment of breast cancer refractory to hormonal and combination chemotherapyCancer, 1978
- Chemo Immunotherapy of Advanced Breast Cancer With BCGPublished by Springer Nature ,1977
- Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancerCancer, 1975
- Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancerCancer, 1975
- The chemical therapy of breast cancer.1974
- Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumorsPublished by Elsevier ,1973